Ketamine vs. Antidepressants: How They Compare for Treatment-Resistant Depression

If you're reading this, you've probably already tried antidepressants. Maybe several of them. Maybe you're on one now and it's helping some, but not enough. Maybe none of them worked at all.

Understanding how ketamine compares to traditional antidepressants isn't about declaring one "better" — it's about understanding your options so you can make informed decisions with your doctor. Here's an honest comparison.

Different Mechanisms, Different Timelines

The most important difference between ketamine and traditional antidepressants is how they work in the brain.

Traditional Antidepressants (SSRIs, SNRIs, etc.)

SSRIs like sertraline, fluoxetine, and escitalopram work by blocking the reuptake of serotonin, increasing its availability in the synaptic cleft. SNRIs like venlafaxine and duloxetine do the same for both serotonin and norepinephrine.

The problem: the serotonin hypothesis of depression — while useful — is almost certainly incomplete. Many patients don't respond to serotonin-based treatments, suggesting their depression involves different neurochemical pathways.

Timeline: 4-6 weeks for full therapeutic effect. Some patients notice improvement in 2 weeks; others wait 8 or more. During this waiting period, side effects often arrive before benefits.

Ketamine

Ketamine works on the glutamate system via NMDA receptor antagonism. This triggers a cascade that promotes synaptogenesis — the growth of new neural connections — particularly in brain regions affected by depression.

Timeline: Hours to days. Many patients notice improvement after their first session. This rapid onset is not just convenient — it's clinically significant for patients with severe symptoms.

Efficacy Comparison

First-Line Treatment

For a first episode of mild-to-moderate depression, SSRIs remain the appropriate starting point. They're well-studied, generally well-tolerated, affordable, and effective for roughly 50-60% of patients. There's no reason to jump to ketamine for a first episode that hasn't been treated.

After One or Two Medication Failures

This is where things get interesting. After failing one antidepressant, the STAR*D trial showed that switching to another antidepressant achieves remission in about 25% of patients. After two failures, the rate drops further. Each subsequent trial has diminishing returns.

Ketamine enters the picture here. In treatment-resistant populations — patients who've failed 2 or more adequate antidepressant trials — ketamine shows response rates of 60-70%. That's substantially higher than the expected response rate from trying yet another traditional antidepressant.

Severe or Acute Depression

For patients with severe depression, particularly with suicidal ideation, the speed of ketamine's effect is its most compelling advantage. Waiting 4-6 weeks for an SSRI to work when someone is in crisis isn't just frustrating — it can be dangerous. Ketamine's rapid onset fills a critical gap that no traditional antidepressant can match.

Side Effect Profiles

Traditional Antidepressants — Ongoing Side Effects

SSRIs and SNRIs come with a well-documented side effect profile that persists as long as you take the medication:

• Sexual dysfunction (reduced libido, difficulty with orgasm) — affects up to 40-60% of patients
• Weight gain — particularly common with paroxetine, mirtazapine, and others
• Emotional blunting — the feeling of being "flat" or unable to experience the full range of emotions
• Sleep disruption — insomnia or hypersomnia depending on the medication
• GI symptoms — nausea, particularly in the first few weeks
• Discontinuation syndrome — withdrawal-like symptoms when stopping, sometimes severe

These side effects are a major reason patients stop taking antidepressants. The treatment works, but the cost in quality of life can be significant.

Ketamine — Acute, Time-Limited Side Effects

Ketamine's side effects are different in character: they're acute (occurring during and shortly after dosing) and time-limited (resolving within hours):

• Dissociation — feeling detached from body or surroundings
• Nausea — usually mild, manageable with anti-nausea medication
• Dizziness
• Increased blood pressure — temporary, typically resolves within 2 hours
• Perceptual changes — altered visual or auditory perception

Notably absent from ketamine's side effect profile: sexual dysfunction, weight gain, and emotional blunting. For patients who've struggled with these SSRI side effects, that's significant.

The trade-off is that ketamine requires periodic dosing sessions where you experience these acute effects, whereas antidepressants are a daily pill with chronic but often tolerable side effects.

Duration and Maintenance

Antidepressants

• Taken daily, typically for months to years
• Many patients remain on them indefinitely for relapse prevention
• Discontinuation requires gradual tapering to avoid withdrawal

Ketamine

• Individual sessions rather than daily dosing
• Initial series of 6+ sessions followed by maintenance
• Maintenance frequency varies: weekly, biweekly, or monthly
• Effects from a single session typically last days to weeks
• Some patients eventually space sessions further apart; others need consistent ongoing treatment

The Cost Question

This matters practically, so I'll be direct:

Antidepressants are cheap. Generic SSRIs cost $4-$20/month. Insurance covers them almost universally. This is a significant advantage.

Ketamine therapy is expensive. IV infusions: $400-800 per session. Esketamine (Spravato): potentially covered by insurance but often with high copays. At-home sublingual ketamine: $200-400+ per month depending on the provider and dosing schedule. Most formulations are not covered by insurance.

Cost shouldn't determine medical decisions, but it does. A patient who responds to a $10/month generic SSRI doesn't need ketamine. A patient who's failed three SSRIs and is still depressed needs to weigh the cost of ketamine against the cost of continuing to suffer.

Can They Be Combined?

Yes. Ketamine and traditional antidepressants are not mutually exclusive. Many patients benefit from combining them — using an SSRI or SNRI as a baseline treatment and adding ketamine for residual symptoms or acute flares.

There are some theoretical concerns about combining ketamine with certain medications (MAOIs should generally be avoided, and some medications may affect ketamine metabolism), so this should be managed by a physician familiar with both.

My Honest Take

Traditional antidepressants should remain first-line for most patients with depression. They work for a majority of people, they're affordable, and they have decades of safety data.

But the profession needs to get over its hesitancy about ketamine for patients who don't respond to traditional treatment. The evidence is strong. The mechanism is sound. The risk-benefit ratio for treatment-resistant depression clearly favors it.

If you've tried two or more antidepressants without adequate relief, ketamine isn't an exotic or fringe option — it's the logical next step. At Coral Health, I help patients evaluate whether ketamine therapy is right for their specific situation, considering their full treatment history, current medications, and goals.

The worst thing we can do for patients with treatment-resistant depression is keep prescribing the same class of medication and expecting different results. When the approach isn't working, it's time for a different approach.